Hepatology communications
Prospective comparative assessment of liver stiffness and steatosis between iLivTouch and FibroScan
By Nuñez-Mercado F, Juárez-Hernández E, Gómez-Mendoza RA and 4 others.
Abstract
Background
Metabolic dysfunction-associated steatotic liver disease currently represents the leading cause of chronic liver disease worldwide. FibroScan and iLivTouch are 2 devices that employ similar principles to estimate liver steatosis and fibrosis, although few studies have directly compared their results.
Aim
To evaluate the concordance of 2 transient elastography devices for the estimation of liver steatosis and fibrosis.
Methods
A prospective study was conducted. Each participant underwent liver elastography with both devices consecutively under standardized conditions. Clinical, anthropometric, and biochemical variables were collected. The diagnostic accuracy of iLivTouch was calculated using FibroScan and noninvasive scores as references.